Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653184 · ClinicalTrials.gov registry record · NA
Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01653184 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 30 participants.
The verdict
NCT01653184, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The effect of omega-3-fatty acids on blood levels omega-3 fatty acids in patients with age-related macular degeneration.
Interventions
- DIETARY_SUPPLEMENT Omega-3 fatty acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01653184
The ClinicalTrials.gov registry entry for NCT01653184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omega-3 fatty acid is the first listed.
NCT01653184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01653184 about?
NCT01653184 is a clinical study titled "Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration". The effect of omega-3-fatty acids on blood levels omega-3 fatty acids in patients with age-related macular degeneration.
What is the current status of trial NCT01653184?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01653184?
The interventions under investigation include: Omega-3 fatty acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01653184?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.